Literature DB >> 15813582

Disclosing genetic test results to family members.

Rebekah J Hamilton1, Barbara J Bowers, Janet K Williams.   

Abstract

PURPOSE: To describe the experiences of disclosing genetic test results to biological family members among people tested for Huntington's disease (HD) or hereditary breast and ovarian cancer (HBOC).
DESIGN: Grounded theory methodology.
METHODS: Open-ended, tape-recorded interviews were conducted with 29 participants-24 who had received genetic test results and 5 who had decided not to be tested. The participants were from three countries, including 15 U.S. states. Interviews occurred from 2 months to 4 years after receiving test results. Tapes were transcribed and analyzed for conceptual categories to describe the experience of disclosing genetic test results.
FINDINGS: Participants described the effects and meaning of disclosing test results to their various family members, and they selectively disclosed results to family members. The timing of disclosure was influenced by the particular disease and the person's perceived need to prepare. Disclosure of genetic test results brought the risk of HD and HBOC to the foreground, not only for the person tested but for family members as well.
CONCLUSIONS: This study elucidated the perspective of the "discloser" and the consequences they anticipated and experienced.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  2005        PMID: 15813582     DOI: 10.1111/j.1547-5069.2005.00007.x

Source DB:  PubMed          Journal:  J Nurs Scholarsh        ISSN: 1527-6546            Impact factor:   3.176


  35 in total

Review 1.  Communicating genetic risk information within families: a review.

Authors:  Mel Wiseman; Caroline Dancyger; Susan Michie
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  The development of a methodology for examining the process of family communication of genetic test results.

Authors:  Jonathan A Smith; Caroline Dancyger; Melissa Wallace; Chris Jacobs; Susan Michie
Journal:  J Genet Couns       Date:  2010-09-11       Impact factor: 2.537

3.  Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives.

Authors:  Afsaneh Hayat Roshanai; Claudia Lampic; Richard Rosenquist; Karin Nordin
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

4.  "Social separation" among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation.

Authors:  Regina Kenen; Audrey Ardern-Jones; Rosalind Eeles
Journal:  J Genet Couns       Date:  2006-06       Impact factor: 2.537

5.  Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales.

Authors:  Nadine A Kasparian; Claire E Wakefield; Bettina Meiser
Journal:  J Genet Couns       Date:  2007-08-13       Impact factor: 2.537

6.  Decision-making about inherited cancer risk: exploring dimensions of genetic responsibility.

Authors:  Holly Etchegary; Fiona Miller; Sonya deLaat; Brenda Wilson; June Carroll; Mario Cappelli
Journal:  J Genet Couns       Date:  2009-03-18       Impact factor: 2.537

Review 7.  Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information.

Authors:  Gillian Nycum; Denise Avard; Bartha M Knoppers
Journal:  Eur J Hum Genet       Date:  2009-03-25       Impact factor: 4.246

8.  Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility families.

Authors:  June A Peters; Regina Kenen; Lindsey M Hoskins; Laura M Koehly; Barry Graubard; Jennifer T Loud; Mark H Greene
Journal:  J Genet Couns       Date:  2011-05-06       Impact factor: 2.537

9.  Grounded theory in genetic counseling research: an interpretive perspective.

Authors:  Robin E Grubs; Maria Piantanida
Journal:  J Genet Couns       Date:  2010-02-02       Impact factor: 2.537

Review 10.  Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.

Authors:  Scott Y H Kim; Jason Karlawish; Benjamin E Berkman
Journal:  Neurology       Date:  2015-03-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.